Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial
Titel:
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial
Auteur:
Camps, C. Massuti, B. Jiménez, A. Maestu, I. Gómez, R. García Isla, D. González, J.L. Almenar, D. Blasco, A. Rosell, R. Carrato, A. Viñolas, N. Batista, N. Girón, C. García Galán, A. López, M. Blanco, R. Provencio, M. Diz, P. Felip, E.